title: First Case Report of Campylobacter volucris Bacteremia in an Immunocompromised Patient.
abstract: We report a case of Campylobacter volucris bacteremia in an immunocompromised patient with polycythemia vera and alcoholic liver cirrhosis. To our knowledge, this is the first case report in which this organism has been isolated from a human clinical specimen.
authors.affiliation: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, South Korea.
authors.forename: Oh Joo
authors.initials: OJ
authors.lastname: Kweon
authors.affiliation: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, South Korea.
authors.forename: Yong Kwan
authors.initials: YK
authors.lastname: Lim
authors.affiliation: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, South Korea.
authors.forename: Byeongpil
authors.initials: B
authors.lastname: Yoo
authors.affiliation: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, South Korea.
authors.forename: Hye Ryoun
authors.initials: HR
authors.lastname: Kim
authors.affiliation: Department of Urology, Chung-Ang University College of Medicine, Seoul, South Korea.
authors.forename: Tae-Hyoung
authors.initials: TH
authors.lastname: Kim
authors.affiliation: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, South Korea cpworld@cau.ac.kr.
authors.forename: Mi-Kyung
authors.initials: MK
authors.lastname: Lee
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia; D002167:Campylobacter / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D002169:Campylobacter Infections; D024881:Drug Resistance, Bacterial; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D000077731:Meropenem; D013845:Thienamycins / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem
references.citation: Case Rep Nephrol Urol. 2012 Jul;2(2):145-51
references.pmid: 23197970
references.citation: Transpl Int. 1998;11(6):439-42
references.pmid: 9870273
references.citation: Clin Microbiol Infect. 2001 Feb;7(2):96-7
references.pmid: 11298152
references.citation: J Clin Pathol. 1994 Feb;47(2):174-5
references.pmid: 8132835
references.citation: Intern Med. 2007;46(9):605-9
references.pmid: 17473499
references.citation: Clin Infect Dis. 2011 Oct;53(8):e99-e106
references.pmid: 21921217
references.citation: Genome Biol Evol. 2014 Dec;6(12):3252-66
references.pmid: 25381664
references.citation: Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1870-5
references.pmid: 19767353
references.citation: FEMS Microbiol Lett. 2002 Jan 2;206(1):107-13
references.pmid: 11786265
references.citation: Int J Syst Evol Microbiol. 2009 May;59(Pt 5):1126-32
references.pmid: 19406805
references.citation: J Clin Microbiol. 1996 Apr;34(4):818-23
references.pmid: 8815090
references.citation: N Engl J Med. 1981 Dec 10;305(24):1444-52
references.pmid: 7029281
references.citation: J Med Microbiol. 2007 Nov;56(Pt 11):1565-7
references.pmid: 17965362
references.citation: Ann Intern Med. 1992 Aug 1;117(3):202-8
references.pmid: 1616214
references.citation: J Antimicrob Chemother. 1996 Apr;37(4):747-57
references.pmid: 8722540
references.citation: Ann Intern Med. 1984 Jul;101(1):55-7
references.pmid: 6375505
references.citation: Epidemiol Infect. 1993 Jun;110(3):567-73
references.pmid: 8519321
references.citation: Clin Infect Dis. 1998 Jul;27(1):220-1
references.pmid: 9675486
references.citation: Antimicrob Agents Chemother. 2010 Mar;54(3):1232-6
references.pmid: 20038624